Artiva Biotherapeutics, Inc. ARTV Current maturities of long-term debt
Current maturities of long-term debt at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s current maturities of long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s current maturities of long-term debt?
- Artiva Biotherapeutics, Inc. (ARTV) reported current maturities of long-term debt of $11K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s current maturities of long-term debt changed year-over-year?
- Artiva Biotherapeutics, Inc.'s current maturities of long-term debt decreased by 91.3% year-over-year, from $126K to $11K.